Skip to main content
Caplight Logo









FluGen, Inc.

FluGen, Inc.

Private
Madison, WisconsinHealthcare & Life Scienceshttp://flugen.com/

Last Round

Grant

Jul 1, 2021

Total Funding Raised

$41.8M

Company Overview

FluGen, Inc. is a biotechnology company developing vaccines for influenza and other respiratory diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Drug Discovery

Business Model

B2B

Customer Profile

Government Contracts

AI Layer

Non-AI

Keywords

universal flu vaccineinfluenza vaccineintranasal vaccinenasal spray vaccineM2SR vaccine platformlive-virus vaccinesingle replication vaccinevaccine developmentrespiratory disease vaccineclinical-stage biotechnologycombination vaccineCOVID/Influenza vaccinemucosal immunitygovernment contractsB2G

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

FluGen, Inc. Comparables

Compare FluGen, Inc. with similar companies based on industry and business-model similarity.

FluGen, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Vivaldi Biosciences, Inc.
93%
Osivax
87%
Blue Lake Biotechnology, Inc.
82%

FluGen, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJul 1, 2021
GrantOct 18, 2017
Series A ExtensionApr 12, 2017
Series AAug 25, 2015
VC RoundFeb 21, 2011
Angel
May 8, 2008

Key People

Founding team and executive leadership

Paul Radspinner

President & CEO

Executive Team

FluGen, Inc. Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 26, 2026

    Monthly visitors increased 114% MoM, reaching 3.6K.

  • Jun 1, 2025

    Monthly visitors increased 30% MoM, reaching 1.1K.

FluGen, Inc. Filings

Explore SEC and related filing metadata, where available.

FluGen, Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about FluGen, Inc.'s valuation, stock price, and market status.

Is FluGen, Inc. a public or private company?

FluGen, Inc. is a private company.

What is the current stock price of FluGen, Inc.?

FluGen, Inc. is a private company with no public stock price. No recent secondary market data is available.

How much is FluGen, Inc. worth (valuation)?

Valuation information for FluGen, Inc. is not publicly available.

Can I buy FluGen, Inc. stock?

FluGen, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was FluGen, Inc.'s last funding round?

FluGen, Inc.'s most recent funding round was Grant on July 1, 2021.

Who are the main investors in FluGen, Inc.?

Key investors in FluGen, Inc. include Venture Investors LLC.

Will FluGen, Inc. IPO soon?

No public IPO plans have been announced for FluGen, Inc..

How can I track FluGen, Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor FluGen, Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersMadison, Wisconsin
Employee Range7
Year Founded2007
Last FundingJul 1, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?